Structure–activity relationships of 1,5-dihydro-2 H -benzo[ b ][1,4]diazepine-2,4(3 H )-diones as inhibitors of Trypanosoma cruzi
- 6 June 2025
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 16 (9) , 4138-4153
Abstract
Two related series of benzodiazepinediones were synthesised, profiled for their suitability as novel treatments for Chagas disease, and progressed to a T. cruzi washout assay.Keywords
Funding Information
- Wellcome Trust (203134/Z/16/Z)
- Wellcome Trust (224024/Z/21/Z)
This publication has 30 references indexed in Scilit:
- Pharmacological and structural understanding of the Trypanosoma cruzi proteasome provides key insights for developing site-specific inhibitorsJournal of Biological Chemistry, 2024
- Chagas diseaseThe Lancet, 2023
- Identification and development of a series of disubstituted piperazines for the treatment of Chagas diseaseEuropean Journal of Medicinal Chemistry, 2022
- New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trialThe Lancet Infectious Diseases, 2021
- Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trialThe Lancet Infectious Diseases, 2018
- Use of Calculated Physicochemical Properties to Enhance Quantitative Response When Using Charged Aerosol DetectionAnalytical Chemistry, 2017
- Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticityDrug Discovery Today, 2011
- Trypanocidal drugs: mechanisms, resistance and new targetsExpert Reviews in Molecular Medicine, 2009
- 4-(Benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: Potent and selective p70S6 kinase inhibitorsBioorganic & Medicinal Chemistry Letters, 2009
- Solid phase synthesis of 6-acylamino-1-alkyl/aryl-4-oxo-1,4-dihydrocinnoline-3-carboxamidesTetrahedron, 2004